EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Radiotherapy and Chemoradiotherapy in Patients Aged ≥70 Years with Stage III Non-Small Cell Lung Cancer: A Retrospective Single-Center Analysis

Melek YAKAR, Durmuş ETİZ, Cengiz BAL, Berk PEKPINARLI

Turkish Journal of Oncology · 2026

DOI: 10.5505/tjo.2026.33544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Oncology, 2026. Verfasst von Melek YAKAR und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE The aim of the study is to evaluate overall survival (OS) and radiation pneumonitis (RP) in patients aged ≥70 years with stage III non-small cell lung cancer (NSCLC) treated with definitive radiotherapy (RT) or concurrent chemoradiotherapy (CRT). METHODS A retrospective analysis included 104 patients. Clinical, dosimetric, and treatment-related factors were assessed. Survival was analyzed using Kaplan–Meier and Cox regression models. RESULTS Median OS was 21 months (95% confidence interval: 17–24). Univariate analysis showed associations between OS and Karnofsky Performance Status, tumor volume, total mean lung dose (tMLD), histopa-thology, chemotherapy use and regimen, RP grade, and RT response. Multivariate analysis identified planning target volume, tMLD, RT response, and RP as independent predictors of OS. RP severity was significantly associated with comorbidities, lymph node location, chemotherapy regimen, and higher lung dose-volume parameters (tV50–60, iV45–60). CONCLUSION OS in elderly stage III NSCLC patients is influenced by tumor response and lung dosimetry. RP inde-pendently worsens survival. Treatment decisions should rely on functional status rather than age, and concurrent CRT is feasible in selected patients.

Zitieren

APA

YAKAR, M., ETİZ, D., BAL, C., & PEKPINARLI, B. (2026). Outcomes of Radiotherapy and Chemoradiotherapy in Patients Aged ≥70 Years with Stage III Non-Small Cell Lung Cancer: A Retrospective Single-Center Analysis. Turkish Journal of Oncology. https://doi.org/10.5505/tjo.2026.33544

Vancouver

YAKAR M, ETİZ D, BAL C, PEKPINARLI B. Outcomes of Radiotherapy and Chemoradiotherapy in Patients Aged ≥70 Years with Stage III Non-Small Cell Lung Cancer: A Retrospective Single-Center Analysis. Turkish Journal of Oncology. 2026. doi:10.5505/tjo.2026.33544

BibTeX
@article{YAKAR2026,
  author = {YAKAR, Melek and ETİZ, Durmuş and BAL, Cengiz and PEKPINARLI, Berk},
  title = {Outcomes of Radiotherapy and Chemoradiotherapy in Patients Aged ≥70 Years with Stage III Non-Small Cell Lung Cancer: A Retrospective Single-Center Analysis},
  journal = {Turkish Journal of Oncology},
  year = {2026},
  doi = {10.5505/tjo.2026.33544}
}
Kostenlos starten →